Mundipharma CEO Raman Singh wins Executive of the Year at SBR Management Excellence Awards

Singh scores a hat trick at the annual awards event for top business leaders in the Lion City.

Singapore, 28 November 2019: Mundipharma CEO, Raman Singh has been named Executive of the Year for the third year running at Singapore Business Review’s (SBR) Management Excellence Awards, held at Conrad Centennial Singapore on 26 November.

SBR’s Management Excellence Awards honour selected business individuals whose unparalleled vision drives growth and innovation in the business landscape. Mr. Singh’s acute understanding of the pharmaceutical industry and human-centric approach has helped Mundipharma work across different markets in Asia and other regions, build successful public-private and academic partnerships, and leverage growth for the company in the right direction.

On winning the award, Mr. Singh stated, “I am honoured to receive this award on behalf of a committed team of people who turn up every day to lead in vital areas of our business so that the lives of patients can be made better. The number-one value underpinning our culture — is putting people and patients at the heart of everything we do. This award reflects the culture we’ve created and the people who embody it.”

Mr. Singh’s win attests to his thought leadership and business acumen that has allowed Mundipharma to be recognised as one of the best companies to work for in Asia. Under his leadership, the company has signed over 40 in-licensing/acquisition deals across multiple therapy areas, and now provides patients with over 48 medicines in seven diversified therapeutic areas.

This latest accolade follows other wins for Mr. Singh including being named Executive of the Year – For Small Cap & Private Pharma Companies at the annual Scrip Awards, in 2018. In addition, he was also awarded CEO of the Year 2018 – Influential Brands; Executive of the Year, Pharmaceuticals, 2018 – SBR; Top 100 Global CEOs 2018 – CEO Magazine; and has been ranked among the world’s most powerful Business Captains on a list of the Top 100 medical and pharmaceutical sector leaders by UK-based industry publication, the Medicine Maker. 2019 is the fifth year in succession that Mr. Singh has been featured on the Power List.

The Singapore Business Review Management Excellence Awards was held on 26 November 2019 at the Conrad Centennial Singapore.

The 2019 nominees were judged by a panel consisting of Henry Tan, Group CEO and Chief Innovation Officer at NEXIA TS; David Chew, Executive Director, Risk Advisory at Deloitte Southeast Asia; Lim Wei Wei, Partner and Practice Leader, Governance and Risk at Baker Tilly TFW; Yang Eu Jin, Partner and Co Head of Capital Markets Practice at RHTLaw Taylor Wessing LLP; and Pardeep Singh Khosa, Director of Dispute Resolution at Davinder Singh Chambers LLC.

If you would like to join the 2020 awards and be awarded as one of the most outstanding management executives of Singapore, please email julie@charltonmediamail.com